Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease

被引:60
作者
Misko, IS [1 ]
Cross, SM [1 ]
Khanna, R [1 ]
Elliott, SL [1 ]
Schmidt, C [1 ]
Pye, SJ [1 ]
Silins, SL [1 ]
机构
[1] Univ Queensland, Queensland Inst Med Res & Joint Expt Oncol, Epstein Barr Virus Unit, Brisbane, Qld 4029, Australia
关键词
D O I
10.1073/pnas.96.5.2279
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The immunodominant, CD8(+) cytotoxic T lymphocyte (CTL) response to the HLA-B8-restricted peptide, RAK-FKQLL, located in the Epstein-Barr virus immediate-early antigen, BZLF1, is characterized by a diverse T cell receptor (TCR) repertoire. Here, we show that this diversity can be partitioned on the basis of crossreactive cytotoxicity patterns involving the recognition of a self peptide-RSKFRQIV-located in a serine/threonine kinase and a bacterial peptide RRKYKQII-located in Staphylococcus aureus replication initiation protein. Thus CTL clones that recognized the viral, self, and bacterial peptides expressed a highly restricted ap TCR phenotype. The CTL clones that recognized viral and self peptides were more oligoclonal, whereas clones that strictly recognized the viral peptide displayed a diverse TCR profile. Interestingly, the self and bacterial peptides equally were substantially less effective than the cognate viral peptide in sensitizing target cell lysis, and also resulted only in a weak reactivation of memory CTLs in limiting dilution assays, whereas the cognate peptide,vas highly immunogenic. The described cross-reactions show that human antiviral, CD8(+) Cm responses can be shaped by peptide ligands derived from autoantigens and environmental bacterial antigens, thereby providing a firm structural basis for molecular mimicry involving class I-restricted CTLs in the pathogenesis of autoimmune disease.
引用
收藏
页码:2279 / 2284
页数:6
相关论文
共 53 条
[31]  
Mousavi-Jazi M, 1998, J RHEUMATOL, V25, P623
[32]   ABLATION OF TOLERANCE AND INDUCTION OF DIABETES BY VIRUS-INFECTION IN VIRAL-ANTIGEN TRANSGENIC MICE [J].
OHASHI, PS ;
OEHEN, S ;
BUERKI, K ;
PIRCHER, H ;
OHASHI, CT ;
ODERMATT, B ;
MALISSEN, B ;
ZINKERNAGEL, RM ;
HENGARTNER, H .
CELL, 1991, 65 (02) :305-317
[33]   MOLECULAR MIMICRY AND AUTOIMMUNE-DISEASE [J].
OLDSTONE, MBA .
CELL, 1987, 50 (06) :819-820
[34]   VIRUS-INFECTION TRIGGERS INSULIN-DEPENDENT DIABETES-MELLITUS IN A TRANSGENIC MODEL - ROLE OF ANTI-SELF (VIRUS) IMMUNE-RESPONSE [J].
OLDSTONE, MBA ;
NERENBERG, M ;
SOUTHERN, P ;
PRICE, J ;
LEWICKI, H .
CELL, 1991, 65 (02) :319-331
[35]   PHAGOCYTIC PROCESSING OF BACTERIAL-ANTIGENS FOR CLASS-I MHC PRESENTATION TO T-CELLS [J].
PFEIFER, JD ;
WICK, MJ ;
ROBERTS, RL ;
FINDLAY, K ;
NORMARK, SJ ;
HARDING, CV .
NATURE, 1993, 361 (6410) :359-362
[36]   Lytic replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state [J].
Prang, NS ;
Hornef, MW ;
Jager, M ;
Wagner, HJ ;
Wolf, H ;
Schwarzmann, FM .
BLOOD, 1997, 89 (05) :1665-1677
[37]   Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection [J].
Rickinson, AB ;
Moss, DJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :405-431
[38]   DIFFERENCES IN B-CELL GROWTH PHENOTYPE REFLECT NOVEL PATTERNS OF EPSTEIN-BARR-VIRUS LATENT GENE-EXPRESSION IN BURKITT-LYMPHOMA CELLS [J].
ROWE, M ;
ROWE, DT ;
GREGORY, CD ;
YOUNG, LS ;
FARRELL, PJ ;
RUPANI, H ;
RICKINSON, AB .
EMBO JOURNAL, 1987, 6 (09) :2743-2751
[39]   NONRESPONSIVENESS TO AN IMMUNODOMINANT EPSTEIN-BARR VIRUS-ENCODED CYTOTOXIC LYMPHOCYTE-T EPITOPE IN NUCLEAR ANTIGEN-3A - IMPLICATIONS FOR VACCINE STRATEGIES [J].
SCHMIDT, C ;
BURROWS, SR ;
SCULLEY, TB ;
MOSS, DJ ;
MISKO, IS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9478-9482
[40]   T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis [J].
Scotet, E ;
DavidAmeline, J ;
Peyrat, MA ;
MoreauAubry, A ;
Pinczon, D ;
Lim, A ;
Even, J ;
Semana, G ;
Berthelot, JM ;
Breathnach, R ;
Bonneville, M ;
Houssaint, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1791-1800